Master in Medical Biotechnology

At Alma Mater Studiorum - Università di BOLOGNA, tuition comes to 3,000 EUR per year.

Medical biotechnology applies biological and biotechnological methods to the study, diagnosis, and treatment of human disease. Students in this field typically study molecular biology, genetics, immunology, and pharmacology, alongside laboratory techniques used in the development of diagnostic tools, therapeutic proteins, and other biotechnology-based medical products. The discipline connects basic biological science with its application in clinical and pharmaceutical settings. Typical subjects include gene therapy, molecular diagnostics, cell biology, and the biotechnological methods used to produce vaccines and other therapeutic agents. Students also study how biotechnological research translates into clinical applications, including the regulatory and quality processes involved in developing new medical products. Graduates in medical biotechnology pursue careers in pharmaceutical and biotechnology companies, diagnostic laboratories, hospital and clinical research settings, and regulatory agencies. Many continue into doctoral research in molecular medicine, immunology, or related biomedical fields. This master's program in Medical Biotechnology is offered by Alma Mater Studiorum - Università di Bologna, located in Bologna, Italy. It runs for two years and is taught in English, making it accessible to international students. Admission is open access, meaning applicants who hold a bachelor's degree or an equivalent qualification can apply without a separate entrance examination. Students entering this program typically have an undergraduate background in biotechnology, biology, or a related life science, providing the foundation needed to study how biotechnological methods are applied to understanding and treating disease at the molecular level.